| First Author | Ando T | Year | 2014 |
| Journal | Cell Rep | Volume | 6 |
| Issue | 2 | Pages | 366-76 |
| PubMed ID | 24412367 | Mgi Jnum | J:208823 |
| Mgi Id | MGI:5565070 | Doi | 10.1016/j.celrep.2013.12.029 |
| Citation | Ando T, et al. (2014) Critical role for mast cell Stat5 activity in skin inflammation. Cell Rep 6(2):366-76 |
| abstractText | Atopic dermatitis (AD) is a chronic inflammatory skin disease. Here, we show that phospholipase C-beta3 (PLC-beta3)-deficient mice spontaneously develop AD-like skin lesions and more severe allergen-induced dermatitis than wild-type mice. Mast cells were required for both AD models and remarkably increased in the skin of Plcb3(-/-) mice because of the increased Stat5 and reduced SHP-1 activities. Mast cell-specific deletion of Stat5 gene ameliorated allergen-induced dermatitis, whereas that of Shp1 gene encoding Stat5-inactivating SHP-1 exacerbated it. PLC-beta3 regulates the expression of periostin in fibroblasts and TSLP in keratinocytes, two proteins critically involved in AD pathogenesis. Furthermore, polymorphisms in PLCB3, SHP1, STAT5A, and STAT5B genes were associated with human AD. Mast cell expression of PLC-beta3 was inversely correlated with that of phospho-STAT5, and increased mast cells with high levels of phospho-STAT5 were found in lesional skin of some AD patients. Therefore, STAT5 regulatory mechanisms in mast cells are important for AD pathogenesis. |
